Singular Genomics Announces Participation in the UBS MedTech, Tools and Genomics Summit
August 02 2023 - 3:05PM
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company
leveraging novel next-generation sequencing (NGS) and multiomics
technologies to empower researchers and clinicians, today announced
plans to participate in the UBS MedTech, Tools and Genomics Summit
in Dana Point, California.
Singular Genomics’ management is scheduled to participate in a
panel discussion titled “Emerging Life Science Technologies Across
Genomics and Proteomics” on Wednesday, August 16, 2023, at
7:00 a.m. Pacific Time / 10:00 a.m. Eastern Time. Investors and
other interested parties are invited to listen to a live and
recorded webcast of the presentation at
investor.singulargenomics.com, in the Presentations & Events
section.
About Singular Genomics Systems, Inc. Singular
Genomics is a life science technology company that develops
next-generation sequencing and multiomics technologies. The
commercially available G4 Sequencing Platform is a powerful, highly
versatile benchtop genomic sequencer designed to produce fast and
accurate results. In development, the PX system leverages
Singular’s proprietary sequencing technology, applying it as an in
situ readout to look at RNA and proteins in single cells and
tissue. With these products, Singular Genomics’ mission is to
empower researchers and clinicians to advance science and medicine.
Visit www.singulargenomics.com for more information.
Investor ContactMatt
Clawson949-370-8500ir@singulargenomics.com
Media ContactDan Budwick,
1AB973-271-6085dan@1abmedia.com
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
From May 2024 to Jun 2024
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
From Jun 2023 to Jun 2024